FTXH: First Trust Nasdaq Pharmaceuticals ETF

Performance

FTXH +36.07%

Watchlist

Select an item

RETURNS1DYTD1Y5Y Ann.Max DDSharpeDiv. Yield
FTXH-0.84%+31.24%+36.07%+11.71%-7.47%1.580.67%

Summary

FTXH at a glance

FTXH returned +36.07% over the past year and +11.71% a year over five years. Its worst drop in that year was -7.47%, smaller than 71% of ETFs on Redstone, and its Sharpe ratio of 1.58 beats 97% of ETFs on Redstone. It yields 0.67%.

Current Drawdown

-4.07%

Rolling Volatility

20.53%

Dividends

FTXH dividends

Yield

0.67%

Paid, past year

$0.29

Pays

Quarterly

Growth a year

+15.1%

Per share, by year

2022
$0.30
2023
$0.41
2024
$0.45
2025
$0.46
Past year
$0.29

Yearly return over 5 years

With dividends+11.71%
Price only+10.19%
From dividends+1.52 pts

FTXH paid $0.29 a share over the past year, every quarter. Its yearly rate rose from $0.30 in 2022 to $0.46 in 2025, 15.1% a year. With dividends reinvested it returned +11.71% a year over five years, against +10.19% on price alone.

›All 20 payments since Dec 23, 2021
  • Sep 24, 2026$0.0113
  • Jun 25, 2026$0.092
  • Mar 26, 2026$0.0573
  • Dec 12, 2025$0.1294
  • Sep 25, 2025$0.1453
  • Jun 26, 2025$0.0892
  • Mar 27, 2025$0.0992
  • Dec 13, 2024$0.1304
  • Sep 26, 2024$0.1218
  • Jun 27, 2024$0.1284
  • Mar 21, 2024$0.0676
  • Dec 22, 2023$0.1232
  • Sep 22, 2023$0.0725
  • Jun 27, 2023$0.1179
  • Mar 24, 2023$0.1001
  • Dec 23, 2022$0.1253
  • Sep 23, 2022$0.0911
  • Jun 24, 2022$0.0384
  • Mar 25, 2022$0.0488
  • Dec 23, 2021$0.1101
Actions

Metrics

Risk Indicators

Alpha24.68%
Beta0.50x
Sharpe1.58
Sortino2.57
Omega1.29
Calmar4.83
Martin10.07

Profile

About FTXH

The First Trust Nasdaq Pharmaceuticals ETF seeks investment results that correspond generally to the price and yield (before the Fund’s fees and expenses) of an equity index called the Nasdaq US Smart Pharmaceuticals Index.

From its prospectus, filed Aug 3, 2026
Category
Health Care
Expense ratio
0.60%
Fund size
$1.2B
Inception
Sep 2016